# Effects of Metformin Therapy on Pancreatic and Hepatic Fat Content in Patients of Type 2 Diabetes Mellitus

> **NCT05939921** · NA · COMPLETED · sponsor: **Diabetes Foundation, India** · enrollment: 15 (actual)

## Conditions studied

- Type2diabetes

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT05939921
- **Lead sponsor:** Diabetes Foundation, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-01
- **Primary completion:** 2023-02-28
- **Final completion:** 2023-06-30
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2023-07-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05939921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05939921, "Effects of Metformin Therapy on Pancreatic and Hepatic Fat Content in Patients of Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT05939921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*